表紙:臨床微生物学の世界市場 (~2025年):用途 (食品・製薬・製造・化学・環境)・疾患 (呼吸器・STD・尿路)・製品 (機器・分析装置・試薬)・エンドユーザー (病院・診断ラボ・学術機関)・地域別
市場調査レポート
商品コード
966172

臨床微生物学の世界市場 (~2025年):用途 (食品・製薬・製造・化学・環境)・疾患 (呼吸器・STD・尿路)・製品 (機器・分析装置・試薬)・エンドユーザー (病院・診断ラボ・学術機関)・地域別

Clinical Microbiology Market by Application (Food, Pharma, Manufacturing, Chemical, Environment), Disease (Respiratory, Std, Uti), Product (Instrument, Analyzer, Reagent), End User (Hospital, Diagnostic Lab, Academia) - Global Forecast to 2025

出版日: | 発行: MarketsandMarkets | ページ情報: 英文 220 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=111.41円
臨床微生物学の世界市場 (~2025年):用途 (食品・製薬・製造・化学・環境)・疾患 (呼吸器・STD・尿路)・製品 (機器・分析装置・試薬)・エンドユーザー (病院・診断ラボ・学術機関)・地域別
出版日: 2020年10月13日
発行: MarketsandMarkets
ページ情報: 英文 220 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界の臨床微生物学の市場規模は予測期間中6.5%のCAGRで推移し、2020年の39億米ドルから、2025年には53億米ドルの規模に成長すると予測されています。技術進歩、新型コロナウイルス感染症 (COVID-19) などの流行、官民からの投資の拡大が同市場の成長を推進しています。一方で、一部の国での不利な償還シナリオが市場のさらなる成長の妨げとなっています。

製品タイプ別では、試薬の部門が期間中最大の成長を示すと予測されています。感染症の高い有病率、機器の販売に伴う試薬レンタル契約の増加傾向、ライフサイエンス研究の増加などの要因が同部門の成長を牽引しています。また、疾患区分別では、呼吸器疾患の部門が2019年に最大のシェアを占め、予測期間中も最大のCAGRを示す見通しです。呼吸器疾患の患者数の多さ、新興諸国全体での標的呼吸器疾患(TB、喘息、COPD、気管支炎など)の有病率の上昇、呼吸器感染症の流行などの要因が同部門の成長を牽引しています。

当レポートでは、世界の臨床微生物学の市場を調査し、市場の定義と概要、COVID-19およびその他の市場影響因子の分析、関連法規制、市場規模の推移・予測、用途・疾患・エンドユーザー・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
    • 課題
  • COVID-19の影響
  • 規制シナリオ
  • エコシステム
  • 技術分析
  • 価格分析

第6章 市場分析・予測:用途別

  • 医薬品
  • 食品試験
  • 臨床
  • エネルギー
  • 化学・材料製造
  • 環境

第7章 市場分析・予測:製品別

  • 機器
    • 実験器具
    • 微生物分析装置
  • 試薬
    • 病原体専用キット
    • 一般的試薬

第8章 市場分析・予測:疾患別

  • 呼吸器疾患
  • 菌血症感染症
  • 胃腸疾患
  • 性感染症
  • 尿路感染症
  • 歯周病
  • その他

第9章 市場分析・予測:エンドユーザー別

  • 病院・診断センター
  • カスタムラボサービスプロバイダー
  • 学術機関・研究機関

第10章 市場分析・予測:地域・主要国別

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
    • その他
  • 中南米
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ

第11章 競合情勢

  • 概要
  • 市場シェア分析
  • 競合シナリオ

第12章 企業評価マトリックス・企業プロファイル

  • 企業評価マトリックス:定義・調査手法
  • 企業プロファイル
    • 3M
    • ABBOTT LABORATORIES
    • AGILENT TECHNOLOGIES
    • BECTON, DICKINSON AND COMPANY
    • BIOMERIEUX
    • BIO-RAD LABORATORIES
    • BRUKER CORPORATION
    • DANAHER CORPORATION
    • HOLOGIC, INC.
    • MERCK KGAA
    • NEOGEN CORPORATION
    • QIAGEN
    • ROCHE DIAGNOSTICS
    • SHIMADZU CORPORATION
    • THERMO FISHER SCIENTIFIC
    • EMERGING PLAYERS

第13章 付録

目次
Product Code: MD 3092

The global clinical microbiology market size is projected to reach USD 5.3 billion by 2025 from USD 3.9 billion in 2020, at a CAGR of 6.5%. Factors such as the technological advancements in the market are propelling the growth of the clinical microbiology market. Additionally, rising inclination epidemics like COVID-19 and investments from private and public sectors affect the growth of clinical microbiology market. However, unfavorable reimbursement scenarios in some countries is hampering the growth of this market.

The recent COVID-19 global pandemic has also impacted the clinical microbiology market. Demand from the main end-users has declined as key regions, and countries have imposed social distancing rules and lockdowns. This impact is expected to be short-term, and no adverse effects are to be foreseen after the market gradually reopens.

"The reagent segment to witness the highest growth rate in the clinical microbiology market, by product, during the forecast period."

The reagent segment is expected to witness the highest growth rate during the forecast period. The high growth in this owes to the high prevalence of infectious diseases across major markets (resulting in a growing number of clinical diagnostic procedures), the increasing trend of reagent rental agreements along with instrument sales, and a rising number of life science researches in the field of specific reagents for targeted infectious disease diagnosis and treatment, especially across emerging countries.

"The respiratory diseases accounted for the largest share of the clinical microbiology market, by diseases, in 2019."

The respiratory diseases segment accounted for the largest share of the clinical microbiology market in 2019. This segment is also estimated to register the highest CAGR during the forecast period. The large share and high growth rate of this segment can be attributed to factors such as the large patient population suffering from respiratory diseases, rising prevalence of target respiratory diseases (such as TB, asthma, COPD, and bronchitis) across developing countries, and growth in the number of epidemic outbreaks of respiratory infections.

"The hospitals & diagnostics centers segment accounted for the largest share of the clinical microbiology, by end-users, in 2019"

The hospitals and diagnostic centers segment accounted for the largest market share in 2019. The large share of this segment is attributed to the high incidence of target diseases (such as tuberculosis, HIV-AIDS, malaria, and epidemic diseases), availability of technologically advanced products (such as molecular diagnostic products and PCR and NGS-based instruments) for infectious disease diagnosis, growing awareness among doctors and clinicians regarding the advantages offered by molecular diagnostic products for fast and effective disease diagnosis, and ongoing expansion of healthcare infrastructure across emerging countries.

"The Asia Pacific market to grow at the highest CAGR during the forecast period."

The clinical microbiology market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Government efforts to increase awareness related to genome-based infectious disease diagnosis, supportive regulations for the development and commercialization of advanced clinical microbiology products, rising healthcare expenditure, an increasing number of hospitals and clinical diagnostic laboratories in India and China, expanding research base across India, China, and Japan, and the increasing incidence of infectious diseases are the major factors driving the growth of the APAC clinical microbiology market.

Breakdown of supply-side primary interviews:

  • By Company Type: Tier 1: 25%, Tier 2: 30%, and Tier 3: 45%
  • By Designation: C-level: 23%, D-level: 30%, and Others: 47%
  • By Region: Europe: 30%, North America: 40%, APAC: 22%, Latin America: 6%, and the Middle East & Africa: 2%

The major players operating in the orthopedic braces and supports market are: bioMerieux (France), Danaher Corporation (US), Becton, Dickinson and Company (US), Abbott Laboratories (US), and Roche Diagnostics (Switzerland). Other prominent players include Thermo Fisher Scientific (US), QIAGEN (Netherlands), 3M (US), Bio-Rad Laboratories (US), Bruker Corporation (US), and Hologic (US).

Research Coverage:

This report studies the clinical microbiology market based on the product, application, diseases, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).

Key Benefits of Buying the Report:

This report focuses on various levels of analysis-industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the clinical microbiology market, and high-growth regions and their drivers, restraints, opportunities, and challenges. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

    • FIGURE 1 RESEARCH DESIGN
  • 2.1 SECONDARY DATA
    • 2.1.1 SECONDARY SOURCES
  • 2.2 PRIMARY DATA
    • FIGURE 2 BREAKDOWN OF PRIMARIES: CLINICAL MICROBIOLOGY MARKET
  • 2.3 MARKET ESTIMATION METHODOLOGY
    • FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
    • 2.3.1 REVENUE MAPPING-BASED MARKET ESTIMATION
    • 2.3.2 PROCEDURE-BASED MARKET ESTIMATION
    • FIGURE 4 MARKET SIZE ESTIMATION: CLINICAL MICROBIOLOGY MARKET
    • 2.3.3 PRIMARY RESEARCH VALIDATION
  • 2.4 DATA TRIANGULATION
    • FIGURE 5 DATA TRIANGULATION METHODOLOGY
  • 2.5 RESEARCH ASSUMPTIONS
  • 2.6 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY

    • FIGURE 6 CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
    • FIGURE 7 CLINICAL MICROBIOLOGY MARKET, BY DISEASE, 2020 VS. 2025 (USD MILLION)
    • FIGURE 8 MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
    • FIGURE 9 CLINICAL MICROBIOLOGY MARKET SHARE, BY END USER, 2020 VS. 2025
    • FIGURE 10 GEOGRAPHICAL SNAPSHOT OF THE CLINICAL MICROBIOLOGY MARKET

4 PREMIUM INSIGHTS

  • 4.1 CLINICAL MICROBIOLOGY MARKET OVERVIEW
    • FIGURE 11 RISING INCIDENCE OF INFECTIOUS DISEASES IS DRIVING THE GROWTH OF THE CLINICAL MICROBIOLOGY MARKET
  • 4.2 CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
    • FIGURE 12 INSTRUMENTS SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN 2025
  • 4.3 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET, BY END USER AND COUNTRY (2019)
    • FIGURE 13 HOSPITALS & DIAGNOSTIC CENTERS SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE APAC CLINICAL MICROBIOLOGY MARKET IN 2019
  • 4.4 GEOGRAPHIC ANALYSIS: CLINICAL MICROBIOLOGY MARKET, BY DISEASE (2019)
    • FIGURE 14 RESPIRATORY DISEASES SEGMENT DOMINATES THE GLOBAL CLINICAL MICROBIOLOGY MARKET
  • 4.5 CLINICAL MICROBIOLOGY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 15 ASIA PACIFIC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Technological advancements in disease diagnostics
      • 5.2.1.2 Rising incidence of infectious diseases and growing outbreaks of epidemics
      • 5.2.1.3 Increased funding and public-private investments
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Limited reimbursement policies for microbiology testing procedures
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Improving healthcare infrastructure across emerging countries
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Operational barriers related to the use of diagnostic tests
      • 5.2.4.2 Bundled sales of microbiology testing products - A key challenge for small and emerging reagent manufacturers
  • 5.3 IMPACT OF THE COVID-19 PANDEMIC ON THE CLINICAL MICROBIOLOGY MARKET
  • 5.4 REGULATORY SCENARIO
  • 5.5 ECOSYSTEM COVERAGE
  • 5.6 TECHNOLOGY ANALYSIS
  • 5.7 PRICING ANALYSIS
    • TABLE 1 CLINICAL MICROBIOLOGY PRICING ANALYSIS, BY PRODUCT, 2019 (USD)

6 MICROBIOLOGY TESTING MARKET, BY APPLICATION

  • 6.1 INTRODUCTION
    • TABLE 2 MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • 6.2 PHARMACEUTICAL
    • 6.2.1 GROWING VOLUME OF PHARMACEUTICAL DRUGS MANUFACTURED IS THE MAJOR FACTOR DRIVING MARKET GROWTH
    • TABLE 3 MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)
  • 6.3 FOOD TESTING
    • 6.3.1 FOOD TESTING IS THE FASTEST-GROWING APPLICATION SEGMENT OF THE MARKET
    • TABLE 4 MICROBIOLOGY TESTING MARKET FOR FOOD TESTING APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)
  • 6.4 CLINICAL
    • 6.4.1 GROWING PROCEDURAL VOLUME OF CLINICAL DIAGNOSTIC TESTS WILL PROPEL MARKET GROWTH
    • TABLE 5 MICROBIOLOGY TESTING MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)
  • 6.5 ENERGY
    • 6.5.1 INCREASING CONSUMPTION & PRODUCTION OF BIOFUEL TO DRIVE MARKET GROWTH
    • TABLE 6 MICROBIOLOGY TESTING MARKET FOR ENERGY APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)
  • 6.6 CHEMICAL & MATERIAL MANUFACTURING
    • 6.6.1 CHEMICAL & MATERIAL MANUFACTURING APPLICATIONS TO WITNESS STEADY GROWTH DURING THE FORECAST PERIOD
    • TABLE 7 MICROBIOLOGY TESTING MARKET FOR CHEMICAL AND MATERIAL MANUFACTURING APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)
  • 6.7 ENVIRONMENTAL
    • 6.7.1 RISING INCIDENCE OF AIR- & WATER-BORNE DISEASES TO SUPPORT MARKET GROWTH
    • TABLE 8 MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)

7 CLINICAL MICROBIOLOGY MARKET, BY PRODUCT

  • 7.1 INTRODUCTION
    • TABLE 9 CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • 7.2 INSTRUMENTS
    • TABLE 10 CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 11 CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY DISEASE, 2018-2025 (USD MILLION)
    • TABLE 12 CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • TABLE 13 CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY REGION, 2018-2025 (USD MILLION)
    • 7.2.1 LABORATORY INSTRUMENTS
    • TABLE 14 LABORATORY INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 15 LABORATORY INSTRUMENTS MARKET, BY DISEASE, 2018-2025 (USD MILLION)
    • TABLE 16 LABORATORY INSTRUMENTS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • TABLE 17 LABORATORY INSTRUMENTS MARKET, BY REGION, 2018-2025 (USD MILLION)
      • 7.2.1.1 Incubators
        • 7.2.1.1.1 Incubators will continue to dominate the clinical microbiology instruments market
    • TABLE 18 INCUBATORS MARKET, BY REGION, 2018-2025 (USD MILLION)
      • 7.2.1.2 Gram stainers
        • 7.2.1.2.1 Gram stainers are among the most widely used clinical microbiology instruments
    • TABLE 19 GRAM STAINERS MARKET, BY REGION, 2018-2025 (USD MILLION)
      • 7.2.1.3 Bacterial colony counters
        • 7.2.1.3.1 Bacterial colony counters are used during diagnostic procedures
    • TABLE 20 BACTERIAL COLONY COUNTERS MARKET, BY REGION, 2018-2025 (USD MILLION)
      • 7.2.1.4 Autoclave sterilizers
        • 7.2.1.4.1 Autoclave sterilizers are used to eliminate the risk of microbial contamination
    • TABLE 21 AUTOCLAVE STERILIZERS MARKET, BY REGION, 2018-2025 (USD MILLION)
      • 7.2.1.5 Microbial air samplers
        • 7.2.1.5.1 Microbial air samplers are significant instruments used in diagnosing airborne diseases
    • TABLE 22 MICROBIAL AIR SAMPLERS MARKET, BY REGION, 2018-2025 (USD MILLION)
      • 7.2.1.6 Blood culture systems
        • 7.2.1.6.1 Blood culture systems are used for end-to-end blood sample processing
    • TABLE 23 BLOOD CULTURE SYSTEMS MARKET, BY REGION, 2018-2025 (USD MILLION)
      • 7.2.1.7 Anaerobic culture systems
        • 7.2.1.7.1 Anaerobic culture systems help to maintain an anaerobic environment
    • TABLE 24 ANAEROBIC CULTURE SYSTEMS MARKET, BY REGION, 2018-2025 (USD MILLION)
      • 7.2.1.8 Microbial culture systems
        • 7.2.1.8.1 Microbial culture systems are automated systems for the culturing of samples
    • TABLE 25 MICROBIAL CULTURE SYSTEMS MARKET, BY REGION, 2018-2025 (USD MILLION)
      • 7.2.1.9 Petri dish fillers
        • 7.2.1.9.1 Petri dish fillers are designed to work reliably in the absence of the operator
    • TABLE 26 PETRI DISH FILLERS MARKET, BY REGION, 2018-2025 (USD MILLION)
      • 7.2.1.10 Other laboratory instruments
    • TABLE 27 OTHER LABORATORY INSTRUMENTS MARKET, BY REGION, 2018-2025 (USD MILLION)
    • 7.2.2 MICROBIOLOGY ANALYZERS
    • TABLE 28 MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 29 MICROBIOLOGY ANALYZERS MARKET, BY DISEASE, 2018-2025 (USD MILLION)
    • TABLE 30 MICROBIOLOGY ANALYZERS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • TABLE 31 MICROBIOLOGY ANALYZERS MARKET, BY REGION, 2018-2025 (USD MILLION)
      • 7.2.2.1 Molecular diagnostic instruments
        • 7.2.2.1.1 Molecular diagnostic instruments to register the highest growth in the forecast period
    • TABLE 32 MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET, BY REGION, 2018-2025 (USD MILLION)
      • 7.2.2.2 Microscopes
        • 7.2.2.2.1 Microscopes are particularly helpful during the preliminary identification of pathogens
    • TABLE 33 MICROSCOPES MARKET, BY REGION, 2018-2025 (USD MILLION)
      • 7.2.2.3 Mass spectrometers
        • 7.2.2.3.1 High accuracy of mass spectrometers to drive their adoption
    • TABLE 34 MASS SPECTROMETERS MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 7.3 REAGENTS
    • TABLE 35 CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 36 CLINICAL MICROBIOLOGY REAGENTS MARKET, BY DISEASE, 2018-2025 (USD MILLION)
    • TABLE 37 CLINICAL MICROBIOLOGY REAGENTS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • TABLE 38 CLINICAL MICROBIOLOGY REAGENTS MARKET, BY REGION, 2018-2025 (USD MILLION)
    • 7.3.1 PATHOGEN-SPECIFIC KITS
      • 7.3.1.1 Pathogen-specific kits provide efficient mechanical disruption of difficult-to-lyse microbes
    • TABLE 39 PATHOGEN-SPECIFIC KITS MARKET, BY REGION, 2018-2025 (USD MILLION)
    • 7.3.2 GENERAL REAGENTS
      • 7.3.2.1 General reagents offer significant data reproducibility
    • TABLE 40 GENERAL REAGENTS MARKET, BY REGION, 2018-2025 (USD MILLION)

8 CLINICAL MICROBIOLOGY MARKET, BY DISEASE

  • 8.1 INTRODUCTION
    • TABLE 41 CLINICAL MICROBIOLOGY MARKET, BY DISEASE, 2018-2025 (USD MILLION)
  • 8.2 RESPIRATORY DISEASES
    • 8.2.1 RESPIRATORY DISEASES SEGMENT TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
    • TABLE 42 CLINICAL MICROBIOLOGY MARKET FOR RESPIRATORY DISEASES, BY REGION, 2018-2025 (USD MILLION)
  • 8.3 BLOODSTREAM INFECTIONS
    • 8.3.1 BLOODSTREAM INFECTIONS CAN LEAD TO A REDUCED RISK OF ANTIBIOTIC RESISTANCE
    • TABLE 43 CLINICAL MICROBIOLOGY MARKET FOR BLOODSTREAM INFECTIONS, BY REGION, 2018-2025 (USD MILLION)
  • 8.4 GASTROINTESTINAL DISEASES
    • 8.4.1 GASTROINTESTINAL DISEASES HAVE A HIGHER PREVALENCE IN DEVELOPING COUNTRIES
    • TABLE 44 CLINICAL MICROBIOLOGY MARKET FOR GASTROINTESTINAL DISEASES, BY REGION, 2018-2025 (USD MILLION)
  • 8.5 SEXUALLY TRANSMITTED DISEASES
    • 8.5.1 RISING PREVALENCE OF STDS ACROSS MAJOR MARKETS TO PROPEL THE ADOPTION OF CLINICAL MICROBIOLOGY PRODUCTS
    • TABLE 45 CLINICAL MICROBIOLOGY MARKET FOR SEXUALLY TRANSMITTED DISEASES, BY REGION, 2018-2025 (USD MILLION)
  • 8.6 URINARY TRACT INFECTIONS
    • 8.6.1 GROWING NUMBER OF UTI CASES WILL DRIVE MARKET GROWTH
    • TABLE 46 CLINICAL MICROBIOLOGY MARKET FOR URINARY TRACT INFECTIONS, BY REGION, 2018-2025 (USD MILLION)
  • 8.7 PERIODONTAL DISEASES
    • 8.7.1 EXPANDING PRODUCT PIPELINES OF MARKET PLAYERS TO SUPPORT MARKET GROWTH
    • TABLE 47 CLINICAL MICROBIOLOGY MARKET FOR PERIODONTAL DISEASES, BY REGION, 2018-2025 (USD MILLION)
  • 8.8 OTHER DISEASES
    • TABLE 48 CLINICAL MICROBIOLOGY MARKET FOR OTHER DISEASES, BY REGION, 2018-2025 (USD MILLION)

9 CLINICAL MICROBIOLOGY MARKET, BY END USER

  • 9.1 INTRODUCTION
    • TABLE 49 CLINICAL MICROBIOLOGY MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 9.2 HOSPITALS & DIAGNOSTIC CENTERS
    • 9.2.1 HOSPITALS & DIAGNOSTIC CENTERS ARE THE LARGEST END USERS OF CLINICAL MICROBIOLOGY PRODUCTS
    • TABLE 50 CLINICAL MICROBIOLOGY MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2018-2025 (USD MILLION)
  • 9.3 CUSTOM LAB SERVICE PROVIDERS
    • 9.3.1 CUSTOM LAB SERVICE PROVIDERS ARE THE FASTEST-GROWING END USERS OF THE CLINICAL MICROBIOLOGY MARKET
    • TABLE 51 CLINICAL MICROBIOLOGY MARKET FOR CUSTOM LAB SERVICE PROVIDERS, BY REGION, 2018-2025 (USD MILLION)
  • 9.4 ACADEMIC & RESEARCH INSTITUTES
    • 9.4.1 HIGH PREVALENCE OF INFECTIOUS DISEASES TO SUPPORT MARKET GROWTH
    • TABLE 52 CLINICAL MICROBIOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2025 (USD MILLION)

10 CLINICAL MICROBIOLOGY MARKET, BY REGION

  • 10.1 INTRODUCTION
    • TABLE 53 CLINICAL MICROBIOLOGY MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 10.2 NORTH AMERICA
    • FIGURE 17 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET SNAPSHOT
    • TABLE 54 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 55 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 56 NORTH AMERICA: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 57 NORTH AMERICA: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 58 NORTH AMERICA: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 59 NORTH AMERICA: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 60 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE, 2018-2025 (USD MILLION)
    • TABLE 61 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 10.2.1 US
      • 10.2.1.1 The US is the largest market for clinical microbiology products
    • TABLE 62 US: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 63 US: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 64 US: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 65 US: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 66 US: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • 10.2.2 CANADA
      • 10.2.2.1 Growing number of clinical diagnostic tests to drive market growth in Canada
    • TABLE 67 CANADA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 68 CANADA: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 69 CANADA: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 70 CANADA: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 71 CANADA: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • 10.3 EUROPE
    • TABLE 72 EUROPE: CLINICAL MICROBIOLOGY MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 73 EUROPE: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 74 EUROPE: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 75 EUROPE: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 76 EUROPE: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 77 EUROPE: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 78 EUROPE: CLINICAL MICROBIOLOGY MARKET, BY DISEASE, 2018-2025 (USD MILLION)
    • TABLE 79 EUROPE: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 10.3.1 GERMANY
      • 10.3.1.1 Germany is the largest and fastest-growing market for clinical microbiology products in Europe
    • TABLE 80 GERMANY: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 81 GERMANY: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 82 GERMANY: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 83 GERMANY: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 84 GERMANY: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • 10.3.2 UK
      • 10.3.2.1 High per capita healthcare expenditure in the country to support market growth
    • TABLE 85 UK: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 86 UK: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 87 UK: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 88 UK: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 89 UK: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • 10.3.3 FRANCE
      • 10.3.3.1 Increasing incidence of infectious diseases to drive market growth
    • TABLE 90 FRANCE: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 91 FRANCE: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 92 FRANCE: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 93 FRANCE: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 94 FRANCE: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • 10.3.4 ITALY
      • 10.3.4.1 Increasing R&D investments by pharmaceutical companies will propel the demand for clinical microbiology products
    • TABLE 95 ITALY: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 96 ITALY: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 97 ITALY: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 98 ITALY: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 99 ITALY: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • 10.3.5 SPAIN
      • 10.3.5.1 Growth of Spain's food and dairy industry will support market growth
    • TABLE 100 SPAIN: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 101 SPAIN: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 102 SPAIN: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 103 SPAIN: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 104 SPAIN: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • 10.3.6 REST OF EUROPE
    • TABLE 105 ROE: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 106 ROE: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 107 ROE: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 108 ROE: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 109 ROE: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • 10.4 ASIA PACIFIC
    • FIGURE 18 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET SNAPSHOT
    • TABLE 110 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 111 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 112 ASIA PACIFIC: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 113 ASIA PACIFIC: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 114 ASIA PACIFIC: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 115 ASIA PACIFIC: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 116 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET, BY DISEASE, 2018-2025 (USD MILLION)
    • TABLE 117 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 10.4.1 JAPAN
      • 10.4.1.1 Japan is the largest market for clinical microbiology in the APAC
    • TABLE 118 JAPAN: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 119 JAPAN: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 120 JAPAN: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 121 JAPAN: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 122 JAPAN: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • 10.4.2 CHINA
      • 10.4.2.1 China to register the highest growth during the forecast period
    • TABLE 123 CHINA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 124 CHINA: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 125 CHINA: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 126 CHINA: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 127 CHINA: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • 10.4.3 INDIA
      • 10.4.3.1 High incidence of infectious diseases in the country to drive the demand for clinical microbiology products
    • TABLE 128 INDIA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 129 INDIA: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 130 INDIA: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 131 INDIA: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 132 INDIA: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • 10.4.4 SOUTH KOREA
      • 10.4.4.1 Growing presence of key market players in the region to support market growth
    • TABLE 133 SOUTH KOREA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 134 SOUTH KOREA: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 135 SOUTH KOREA: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 136 SOUTH KOREA: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 137 SOUTH KOREA: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • 10.4.5 AUSTRALIA
      • 10.4.5.1 Limitations with respect to research activities are expected to hamper the growth of the clinical microbiology market in Australia
    • TABLE 138 AUSTRALIA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 139 AUSTRALIA: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 140 AUSTRALIA: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 141 AUSTRALIA: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 142 AUSTRALIA: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • 10.4.6 REST OF APAC
    • TABLE 143 ROAPAC: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 144 ROAPAC: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 145 ROAPAC: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 146 ROAPAC: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 147 ROAPAC: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • 10.5 LATIN AMERICA
    • TABLE 148 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 149 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 150 LATIN AMERICA: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 151 LATIN AMERICA: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 152 LATIN AMERICA: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 153 LATIN AMERICA: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 154 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE, 2018-2025 (USD MILLION)
    • TABLE 155 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 10.5.1 BRAZIL
      • 10.5.1.1 Brazil is the largest market in Latin America for clinical microbiology products
    • TABLE 156 BRAZIL: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 157 BRAZIL: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 158 BRAZIL: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 159 BRAZIL: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 160 BRAZIL: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • 10.5.2 MEXICO
      • 10.5.2.1 Reluctance of healthcare professionals to adopt advanced diagnostic technologies to hamper the market growth
    • TABLE 161 MEXICO: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 162 MEXICO: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 163 MEXICO: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 164 MEXICO: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 165 MEXICO: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • 10.5.3 REST OF LATIN AMERICA
    • TABLE 166 ROLATAM: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 167 ROLATAM: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 168 ROLATAM: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 169 ROLATAM: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 170 ROLATAM: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 INCREASING GOVERNMENT INITIATIVES TO IMPROVE HEALTHCARE INFRASTRUCTURE WILL SUPPORT MARKET GROWTH
    • TABLE 171 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 172 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 173 MIDDLE EAST & AFRICA: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 174 MIDDLE EAST & AFRICA: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 175 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 176 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE, 2018-2025 (USD MILLION)
    • TABLE 177 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2018-2025 (USD MILLION)

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
    • FIGURE 19 KEY DEVELOPMENTS BY LEADING MARKET PLAYERS IN THE CLINICAL MICROBIOLOGY MARKET, JANUARY 2017-AUGUST 2020
  • 11.2 MARKET SHARE ANALYSIS
    • FIGURE 20 CLINICAL MICROBIOLOGY MARKET SHARE, BY KEY PLAYER, 2019
  • 11.3 COMPETITIVE SCENARIO
    • FIGURE 21 PRODUCT LAUNCHES WAS THE KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS
    • 11.3.1 KEY PRODUCT LAUNCHES & APPROVALS
    • 11.3.2 KEY PARTNERSHIPS & COLLABORATIONS
    • 11.3.3 KEY ACQUISITIONS
    • 11.3.4 KEY EXPANSIONS

12 COMPANY EVALUATION MATRIX AND COMPANY PROFILES

  • 12.1 COMPANY EVALUATION MATRIX DEFINITION AND METHODOLOGY
    • 12.1.1 VENDOR INCLUSION CRITERIA
    • 12.1.2 STARS
    • 12.1.3 EMERGING LEADERS
    • 12.1.4 PERVASIVE
    • 12.1.5 PARTICIPANTS
    • FIGURE 22 CLINICAL MICROBIOLOGY MARKET: GLOBAL COMPETITIVE LEADERSHIP MAPPING, 2019
  • 12.2 COMPANY PROFILES

*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

    • 12.2.1 3M
    • FIGURE 23 3M: COMPANY SNAPSHOT (2019)
    • 12.2.2 ABBOTT LABORATORIES
    • FIGURE 24 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2019)
    • 12.2.3 AGILENT TECHNOLOGIES
    • FIGURE 25 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2019)
    • 12.2.4 BECTON, DICKINSON AND COMPANY
    • FIGURE 26 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2019)
    • 12.2.5 BIOMERIEUX
    • FIGURE 27 BIOMERIEUX: COMPANY SNAPSHOT (2019)
    • 12.2.6 BIO-RAD LABORATORIES
    • FIGURE 28 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2019)
    • 12.2.7 BRUKER CORPORATION
    • FIGURE 29 BRUKER CORPORATION: COMPANY SNAPSHOT (2019)
    • 12.2.8 DANAHER CORPORATION
    • FIGURE 30 DANAHER CORPORATION: COMPANY SNAPSHOT (2019)
    • 12.2.9 HOLOGIC, INC.
    • FIGURE 31 HOLOGIC: COMPANY SNAPSHOT (2019)
    • 12.2.10 MERCK KGAA
    • FIGURE 32 MERCK KGAA: COMPANY SNAPSHOT (2019)
    • 12.2.11 NEOGEN CORPORATION
    • FIGURE 33 NEOGEN CORPORATION: COMPANY SNAPSHOT (2019)
    • 12.2.12 QIAGEN
    • FIGURE 34 QIAGEN: COMPANY SNAPSHOT (2019)
    • 12.2.13 ROCHE DIAGNOSTICS
    • FIGURE 35 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT (2019)
    • 12.2.14 SHIMADZU CORPORATION
    • FIGURE 36 SHIMADZU CORPORATION: COMPANY SNAPSHOT (2019)
    • 12.2.15 THERMO FISHER SCIENTIFIC
    • FIGURE 37 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2019)
    • 12.2.16 EMERGING PLAYERS
      • 12.2.16.1 Biotechnology Solutions
      • 12.2.16.2 Hardy Diagnostics
      • 12.2.16.3 Liofilchem
      • 12.2.16.4 Rapid Micro Biosystems
      • 12.2.16.5 TCS Biosciences

(Business Overview, Products Offered, Recent Developments, MnM View)**

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 AVAILABLE CUSTOMIZATIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS